IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

In The News

100 years of a tuberculosis vaccine with limited benefit

Devex

July 15, 2021

Read more

Press Releases

Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials

July 14, 2021

Biofabri and IAVI announce their intention to partner on efficacy trials of the tuberculosis vaccine candidate MTBVAC TB kills 1.4 million people a year, an infectious disease toll only recently surpassed by COVID-19. COVID-19 has reversed years of progress in TB response, costing additional lives and adding to the urgency of the global TB problem.…

Read more

Scientific Publications

Site Specific Steric Control of SARS CoV 2 Spike Glycosylation

Read more

Scientific Publications

Genital abnormalities hormonal contraception and HIV transmission risk in Rwandan serodifferent couples

Read more

Scientific Publications

HIV 1 infection and the lack of viral control are associated with greater expression of interleukin 21 receptor on CD8 T cells

Read more

Scientific Publications

A Rapid Assay for SARS CoV 2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs

Read more

Scientific Publications

Relative efficiency of demand creation strategies to increase voluntary medical male circumcision uptake a study conducted as part of a randomised controlled trial in Zimbabwe

Read more

IAVI Report

IAVI REPORT – VOL. 25, NO. 1, 2021

June 29, 2021

The last time I penned a letter in this publication, nearly a year ago, I closed by saying: “If science is our best hope, we are in good hands.” That certainly proved to be the case. There are now three authorized COVID-19 vaccines in the U.S., and seven that have received an Emergency Use Listing…

Read more